The latest in motor neurone disease
Psychiatric disorders in Parkinson’s disease
NICE guidance on Parkinson’s disease
NICE recently published its quality standard on Parkinson’s with the aim of setting out priority areas for improvement in health and social care in England and Wales. Professor Richard Walker, member of the NICE Guidelines Development Committee and the Quality Standard Advisory Committee, discusses the rationale behind the quality statements.
Dementia: a clinical overview
The biggest risk factor for developing dementia is age. Dementia affects both men and women, with women more likely to develop Alzheimer’s disease and men more likely to develop vascular dementia. Most of these cases affect people over the age of 65 years with only 5% of cases reported below this age.
Clinical management of parkinson’s disease
Lifestyle change and the Prevention of cognitive Decline and dementia
The number of people with dementia, including Alzheimer’s disease, is expected to rise to more than 1.7 million people by 2051, with the burden falling on over-stretched social care services, the NHS and families. It is crucial that we look at what can be done to reduce the risk or delay the onset of developing the disease.
Study finds that sleep disorders affect men and women differently
Can dietary supplements prevent or slow the progression of Alzheimer’s disease? (Part 2)
Identifying and managing pain for patients with advanced dementia (Part 1)
Dietary supplements and the prevention of Alzheimer's Disease
As part of our ongoing series looking at the role of dietary supplements in the prevention of Alzheimer’s disease, this article looks at key principles underlying nutritional interventions to help the clinician judge the validity of the claims and counter-claims that currently exist in available literature.